以儿童期低血糖为表现的代谢性肝病：肝病专家指南
Metabolic Liver Diseases Presenting as Pediatric Onset Hypoglycemia: A Hepatologist's Primer.
作者信息
Verma Snigdha, Sood Vikrant, Lal Bikrant B, Khanna Rajeev, Alam Seema
机构信息
Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
出版信息
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102425. doi: 10.1016/j.jceh.2024.102425. Epub 2024 Oct 11.
Abstract
Hypoglycemia, especially when recurrent or persistent, is an important indicator of inborn metabolic errors. Although commonly encountered by hepatologists, it continues to be a pandora's box as no consensus on the exact definition and diagnostic work up exists. Here, we present four interesting pediatric cases of varied age groups, presenting with hypoglycemia as their major symptomatology. We also attempted to provide a systematic diagnostic guide for a refined and targeted approach to inherited metabolic liver diseases presenting with hypoglycemia.
摘要
低血糖，尤其是反复发生或持续存在时，是先天性代谢缺陷的重要指标。尽管肝病学家经常遇到这种情况，但它仍然是一个潘多拉魔盒，因为对于确切的定义和诊断检查尚无共识。在此，我们展示了四个不同年龄组的有趣儿科病例，均以低血糖为主要症状。我们还试图为以低血糖为表现的遗传性代谢性肝病提供一种系统的诊断指南，以采取精确且有针对性的方法。
相似文献
1
Metabolic Liver Diseases Presenting as Pediatric Onset Hypoglycemia: A Hepatologist's Primer.以儿童期低血糖为表现的代谢性肝病：肝病专家指南
J Clin Exp Hepatol. 2025 Jan-Feb;15(1):102425. doi: 10.1016/j.jceh.2024.102425. Epub 2024 Oct 11.
3
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中，如果患者出现以下症状和体征，可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
7
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗：一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).自闭症谱系障碍（ASD）中易怒、攻击行为和自我伤害的药物干预。
Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD011769. doi: 10.1002/14651858.CD011769.pub2.
本文引用的文献
1
Decoding hepatorenal tyrosinemia type 1: Unraveling the impact of early detection, NTBC, and the role of liver transplantation.解读1型肝肾酪氨酸血症：揭示早期检测、NTBC的影响以及肝移植的作用。
Can Liver J. 2024 Feb 26;7(1):54-63. doi: 10.3138/canlivj-2023-0018. eCollection 2024 Feb.
2
Glycogen storage disease type I: Genetic etiology, clinical manifestations, and conventional and gene therapies.I型糖原贮积病：遗传病因、临床表现以及传统治疗和基因治疗
Pediatr Discov. 2023;1(2). doi: 10.1002/pdi3.3. Epub 2023 Jul 24.
3
Hypoglycemia in Children: Major Endocrine-Metabolic Causes and Novel Therapeutic Perspectives.儿童低血糖症：主要的内分泌代谢病因和新的治疗观点。
Nutrients. 2023 Aug 11;15(16):3544. doi: 10.3390/nu15163544.
4
Fifty years of research on mitochondrial fatty acid oxidation disorders: The remaining challenges.线粒体脂肪酸氧化障碍研究五十年：尚存的挑战。
J Inherit Metab Dis. 2023 Sep;46(5):848-873. doi: 10.1002/jimd.12664.
5
French recommendations for the management of glycogen storage disease type III.法国关于 III 型糖原贮积症管理的建议。
Eur J Med Res. 2023 Jul 24;28(1):253. doi: 10.1186/s40001-023-01212-5.
6
Glycogen storage diseases: An update.糖原贮积病：更新。
World J Gastroenterol. 2023 Jul 7;29(25):3932-3963. doi: 10.3748/wjg.v29.i25.3932.
7
Clinical spectrum and genetic causes of mitochondrial hepatopathy phenotype in children.儿童线粒体肝病变表型的临床谱及遗传病因。
Hepatol Commun. 2023 May 15;7(6). doi: 10.1097/HC9.0000000000000139. eCollection 2023 Jun 1.
8
Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource.糖原贮积病Ⅳ型（包括成人多聚葡萄糖体病）的诊断和管理：临床实践资源。
Mol Genet Metab. 2023 Mar;138(3):107525. doi: 10.1016/j.ymgme.2023.107525. Epub 2023 Jan 25.
9
Mitochondrial Hepatopathy.线粒体肝病变
Clin Liver Dis. 2022 Aug;26(3):421-438. doi: 10.1016/j.cld.2022.03.006. Epub 2022 Jun 25.
10
Glycogen storage diseases with liver involvement: a literature review of GSD type 0, IV, VI, IX and XI.伴有肝脏受累的糖原贮积病：GSD 类型 0、IV、VI、IX 和 XI 的文献复习。
Orphanet J Rare Dis. 2022 Jun 20;17(1):241. doi: 10.1186/s13023-022-02387-6.
Zotero 插件